![Mark Erlander](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Erlander
No más puestos en curso
Fortuna: 31 825 $ al 30/06/2026
Perfil
Mark Erlander worked as an Assistant Professor at The Scripps Research Institute from 1991 to 1994.
From 1994 to 2000, served as Principal at Johnson & Johnson.
Held the position of Chief Scientific Officer at Arcturus Studios Holdings, Inc. between 2000 and 2008.
Worked as Chief Scientific Officer at Biotheranostics, Inc. from 2008 to 2013.
Served as Chief Scientific Officer at Gensignia Life Sciences, Inc. from 2013 to 2014.
From 2020 to 2026, was Chief Executive Officer & Director at Cardiff Oncology, Inc. Education includes a doctorate from the University of California, Los Angeles, graduate studies at Iowa State University, and undergraduate studies at the University of California, Davis.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
CARDIFF ONCOLOGY, INC. 0,04 % | 20/04/2026 | 24.481 ( 0,04 % ) | 31 825 $ | 30/06/2026 |
Antiguos cargos conocidos de Mark Erlander.
| Empresas | Cargo | Fin |
|---|---|---|
| CARDIFF ONCOLOGY, INC. | Director Ejecutivo | 27/01/2026 |
Gensignia Life Sciences, Inc.
 Gensignia Life Sciences, Inc. BiotechnologyHealth Technology Operates as a molecular diagnostics company which develop new molecular diagnosis techniques | Director Técnico/Científico/I+D | 01/03/2014 |
Biotheranostics, Inc.
 Biotheranostics, Inc. Medical/Nursing ServicesHealth Services Discovers, develops and commercializes molecular diagnostic tests for cancer patients | Director Técnico/Científico/I+D | 01/02/2013 |
Arcturus Studios Holdings, Inc.
 Arcturus Studios Holdings, Inc. Packaged SoftwareTechnology Services Develops video editing software for live-action performances | Director Técnico/Científico/I+D | 01/01/2008 |
| JOHNSON & JOHNSON | Corporate Officer/Principal | 01/01/2000 |
Formación de Mark Erlander.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
66
Relaciones de 1er grado
9
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 9 |
|---|---|
Johnson & Johnson
 Johnson & Johnson Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in health care products | Health Technology |
Biotheranostics, Inc.
Biotheranostics, Inc. Medical/Nursing ServicesHealth Services Discovers, develops and commercializes molecular diagnostic tests for cancer patients | Health Services |
The Scripps Research Institute
 The Scripps Research Institute Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Los Angeles
 University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Iowa State University
 Iowa State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cardiff Oncology, Inc.
 Cardiff Oncology, Inc. Medical SpecialtiesHealth Technology Develops diagnostic products | Health Technology |
University of California, Davis
 University of California, Davis Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Gensignia Life Sciences, Inc.
Gensignia Life Sciences, Inc. BiotechnologyHealth Technology Operates as a molecular diagnostics company which develop new molecular diagnosis techniques | Health Technology |
Arcturus Studios Holdings, Inc.
Arcturus Studios Holdings, Inc. Packaged SoftwareTechnology Services Develops video editing software for live-action performances | Technology Services |
- Bolsa de valores
- Insiders
- Mark Erlander
